North Chemical Industries Past Earnings Performance
Past criteria checks 0/6
North Chemical Industries's earnings have been declining at an average annual rate of -16.3%, while the Chemicals industry saw earnings growing at 8.1% annually. Revenues have been declining at an average rate of 1.7% per year. North Chemical Industries's return on equity is 1.1%, and it has net margins of 1.7%.
Key information
-16.3%
Earnings growth rate
-16.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -1.7% |
| Return on equity | 1.1% |
| Net Margin | 1.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How North Chemical Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,066 | 36 | 364 | 86 |
| 31 Dec 23 | 2,159 | 56 | 363 | 83 |
| 30 Sep 23 | 2,170 | 17 | 316 | 88 |
| 31 Mar 23 | 2,408 | 86 | 293 | 115 |
| 01 Jan 23 | 2,559 | 93 | 306 | 117 |
| 30 Sep 22 | 2,527 | 134 | 271 | 115 |
| 30 Jun 22 | 2,618 | 132 | 271 | 120 |
| 31 Mar 22 | 2,645 | 110 | 286 | 112 |
| 01 Jan 22 | 2,633 | 122 | 289 | 110 |
| 30 Sep 21 | 2,657 | 96 | 293 | 108 |
| 30 Jun 21 | 2,689 | 111 | 289 | 94 |
| 31 Mar 21 | 2,530 | 115 | 266 | 94 |
| 31 Dec 20 | 2,359 | 90 | 289 | 94 |
| 30 Sep 20 | 2,387 | 98 | 287 | 112 |
| 30 Jun 20 | 2,335 | 95 | 319 | 114 |
| 31 Mar 20 | 2,402 | 133 | 337 | 102 |
| 31 Dec 19 | 2,461 | 137 | 322 | 96 |
| 30 Sep 19 | 2,584 | 157 | 379 | 82 |
| 30 Jun 19 | 2,475 | 136 | 338 | 90 |
| 31 Mar 19 | 2,459 | 133 | 328 | 84 |
| 31 Dec 18 | 2,363 | 124 | 308 | 85 |
| 30 Sep 18 | 2,291 | 117 | 302 | 85 |
| 30 Jun 18 | 2,311 | 118 | 289 | 101 |
| 31 Mar 18 | 2,125 | 92 | 291 | 84 |
| 31 Dec 17 | 2,183 | 108 | 307 | 72 |
| 30 Sep 17 | 2,237 | 105 | 371 | 45 |
| 30 Jun 17 | 2,118 | 121 | 403 | 0 |
| 31 Mar 17 | 2,321 | 143 | 440 | 0 |
| 31 Dec 16 | 2,193 | 138 | 416 | 0 |
| 30 Sep 16 | 1,711 | 115 | 317 | 0 |
| 30 Jun 16 | 1,606 | 101 | 283 | 0 |
| 31 Mar 16 | 1,386 | 58 | 209 | 0 |
| 31 Dec 15 | 1,505 | 55 | 204 | 0 |
| 30 Sep 15 | 1,713 | 64 | 196 | 0 |
| 30 Jun 15 | 1,944 | 65 | 203 | 0 |
| 31 Mar 15 | 1,999 | 66 | 215 | 0 |
| 31 Dec 14 | 2,036 | 73 | 219 | 0 |
| 30 Sep 14 | 2,095 | 71 | 228 | 0 |
| 30 Jun 14 | 2,050 | 60 | 228 | 0 |
| 31 Mar 14 | 2,048 | 53 | 221 | 0 |
| 31 Dec 13 | 2,013 | 49 | 219 | 0 |
| 30 Sep 13 | 1,980 | 49 | 216 | 0 |
| 30 Jun 13 | 1,959 | 50 | 210 | 0 |
Quality Earnings: 002246 has a large one-off loss of CN¥12.4M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 002246's current net profit margins (1.7%) are lower than last year (3.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002246's earnings have declined by 16.3% per year over the past 5 years.
Accelerating Growth: 002246's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002246 had negative earnings growth (-58.6%) over the past year, making it difficult to compare to the Chemicals industry average (-17.2%).
Return on Equity
High ROE: 002246's Return on Equity (1.1%) is considered low.